These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3548098)

  • 21. Recent advances in diabetology: diabetic dermopathy, autoantibodies in the prediction of the development of type 1 diabetes, and islet cell transplantation and inhaled insulin as treatment for diabetes.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2006 Nov; 31(6):837-40. PubMed ID: 16907932
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cost of insulin-dependent diabetes vs cost of its prevention].
    Vardi P; Weitzman S; Shavit T
    Harefuah; 1995 Mar; 128(5):281-5, 335. PubMed ID: 7744348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I diabetes mellitus.
    Pigrau C; Lorente A; Martinez-Vazquez JM
    N Engl J Med; 1986 Dec; 315(24):1552. PubMed ID: 3537788
    [No Abstract]   [Full Text] [Related]  

  • 24. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
    Tsirogianni A; Pipi E; Soufleros K
    Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heterogeneity of diabetes mellitus].
    Asfandiiarova NS; Kolcheva NG; Shatrova IV
    Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of islet cell antibodies and its correlation with glucose and insulin response to oral glucose tolerance test in 1st degree relatives of insulin dependent diabetes mellitus probands.
    Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
    J Assoc Physicians India; 1998 May; 46(5):417-23. PubMed ID: 11273280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
    Batstra MR; Aanstoot HJ; Herbrink P
    Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classification and etiopathogenesis of diabetes mellitus].
    Spahn U
    Kinderarztl Prax; 1986 Feb; 54(2):65-72. PubMed ID: 3517462
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etiopathogenesis of diabetes mellitus].
    Chacra AR
    AMB Rev Assoc Med Bras; 1986; 32(11-12):187-90. PubMed ID: 3299516
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoantibodies as mechanisms, markers, and mediators of B-cell disease.
    Wilkin TJ
    Diabetes Metab Rev; 1991 Jun; 7(2):105-20. PubMed ID: 1794256
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metabolic and immunologic effects of cyclosporine administration in new insulin-dependent diabetics].
    Assan R; Debray-Sachs M; Laborie C; Chatenoud L; Feutren G; Quiniou-Debrie MC; Thomas G; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1985; ():197-9. PubMed ID: 2577963
    [No Abstract]   [Full Text] [Related]  

  • 32. The natural history and predictive value of Mr 64,000 autoantibodies for insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK; Holmes L; Scharp DW; Lacy PE; Riley WJ
    J Autoimmun; 1990 Apr; 3 Suppl 1():41-5. PubMed ID: 2187459
    [No Abstract]   [Full Text] [Related]  

  • 33. [Early detection of type I diabetes].
    Kolb H
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1774. PubMed ID: 2226191
    [No Abstract]   [Full Text] [Related]  

  • 34. Autoimmunity in juvenile diabetes mellitus.
    Nutr Rev; 1979 Feb; 37(2):44-5. PubMed ID: 372863
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunologic abnormalities and type I diabetes.
    Khardori R
    Diabetes Care; 1984; 7(3):304-5. PubMed ID: 6376021
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin autoantibodies as markers for type I diabetes.
    Wilkin TJ
    Endocr Rev; 1990 Feb; 11(1):92-104. PubMed ID: 2180690
    [No Abstract]   [Full Text] [Related]  

  • 37. Peptide secretion triggers diabetes.
    Wei J; Yewdell JW
    Nature; 2018 Aug; 560(7716):33-34. PubMed ID: 30061643
    [No Abstract]   [Full Text] [Related]  

  • 38. DISCUSSION ON THE TREATMENT OF DIABETES MELLITUS BY ALIMENTARY REST.
    Brown WL
    Proc R Soc Med; 1916; 9(Ther Pharmacol Sect):92. PubMed ID: 19979538
    [No Abstract]   [Full Text] [Related]  

  • 39. DISCUSSION ON THE TREATMENT OF DIABETES MELLITUS BY ALIMENTARY REST.
    Cammidge PJ
    Proc R Soc Med; 1916; 9(Ther Pharmacol Sect):92-4. PubMed ID: 19979537
    [No Abstract]   [Full Text] [Related]  

  • 40. DISCUSSION ON THE TREATMENT OF DIABETES MELLITUS BY ALIMENTARY REST.
    Ryffel JH
    Proc R Soc Med; 1916; 9(Ther Pharmacol Sect):90-1. PubMed ID: 19979536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.